Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
D000074:Acenocoumarol / Q000097:blood; D000925:Anticoagulants / Q000097:blood* / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D002994:Clofibrate / Q000494:pharmacology*; D005017:Ethyl Biscoumacetate / Q000097:blood; D006801:Humans; D010630:Phenindione / Q000097:blood; D011485:Protein Binding / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D012709:Serum Albumin / Q000378:metabolism*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000097:blood
D000925:Anticoagulants; D011955:Receptors, Drug; D012709:Serum Albumin; D005017:Ethyl Biscoumacetate; D014812:Vitamin K; D010630:Phenindione; D014859:Warfarin; D002994:Clofibrate; D000074:Acenocoumarol